Matches in SemOpenAlex for { <https://semopenalex.org/work/W4300604358> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W4300604358 endingPage "20" @default.
- W4300604358 startingPage "20" @default.
- W4300604358 abstract "OmniComm Systems, Inc. (OMCM), Miami, Florida, announced it is partnering with Optima WorldWide, Ltd., to launch US testing of a vaginal gel for the potential prevention of pregnancy and the most common sexually transmitted diseases (STDs). Surete Gel, which is already being sold in China as a vaginal disinfectant and contraceptive, is being tested as a potential preventive agent for most STDs, including HIV. The concept of an antimicrobial product that prevents infectious sexual diseases has long been awaited by experts at the WHO and the US National Institutes of Health as an important weapon in preventing the global STD and HIV epidemics. OmniComm's Internet electronic data capture system, TrialMaster, and its web portal for trial investigators and participants, WebIPA.com, will manage long-term testing of Surete Gel worldwide. Stephen Drake, Optima, is hailing the partnership with OmniComm as a big step forward. We are very pleased with this alliance as we complete trials on Surete Gel. This brings us closer to bringing a microbicide gel to the important US market while our vaginal disinfectant and contraceptive is already being introduced abroad. Optima is awaiting approval to sell Surete Gel in India and Thailand, as well as in several African and European nations. OmniComm is expanding its trial investigator base for Surete clinic trials in the US by enrolling experienced US investigators in the field of gynecology. A number of trial participants will be needed to take part in extensive testing before the product can be considered for approval in the US as more than a contraceptive. Surete complies with the US Food and Drug Administration monograph as a contraceptive. Anyone interested in taking part in those clinical trials--investigators or participants--must register thru OmniComm's web portal, WebIPA.com." @default.
- W4300604358 created "2022-10-03" @default.
- W4300604358 date "2000-09-18" @default.
- W4300604358 modified "2023-09-29" @default.
- W4300604358 title "U.S. trials on contraceptive gel begin via the Internet." @default.
- W4300604358 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12296207" @default.
- W4300604358 hasPublicationYear "2000" @default.
- W4300604358 type Work @default.
- W4300604358 citedByCount "0" @default.
- W4300604358 crossrefType "journal-article" @default.
- W4300604358 hasConcept C110875604 @default.
- W4300604358 hasConcept C117214928 @default.
- W4300604358 hasConcept C136764020 @default.
- W4300604358 hasConcept C17744445 @default.
- W4300604358 hasConcept C197746943 @default.
- W4300604358 hasConcept C199539241 @default.
- W4300604358 hasConcept C2908647359 @default.
- W4300604358 hasConcept C29456083 @default.
- W4300604358 hasConcept C2986740045 @default.
- W4300604358 hasConcept C3013748606 @default.
- W4300604358 hasConcept C41008148 @default.
- W4300604358 hasConcept C512399662 @default.
- W4300604358 hasConcept C71750763 @default.
- W4300604358 hasConcept C71924100 @default.
- W4300604358 hasConcept C99454951 @default.
- W4300604358 hasConceptScore W4300604358C110875604 @default.
- W4300604358 hasConceptScore W4300604358C117214928 @default.
- W4300604358 hasConceptScore W4300604358C136764020 @default.
- W4300604358 hasConceptScore W4300604358C17744445 @default.
- W4300604358 hasConceptScore W4300604358C197746943 @default.
- W4300604358 hasConceptScore W4300604358C199539241 @default.
- W4300604358 hasConceptScore W4300604358C2908647359 @default.
- W4300604358 hasConceptScore W4300604358C29456083 @default.
- W4300604358 hasConceptScore W4300604358C2986740045 @default.
- W4300604358 hasConceptScore W4300604358C3013748606 @default.
- W4300604358 hasConceptScore W4300604358C41008148 @default.
- W4300604358 hasConceptScore W4300604358C512399662 @default.
- W4300604358 hasConceptScore W4300604358C71750763 @default.
- W4300604358 hasConceptScore W4300604358C71924100 @default.
- W4300604358 hasConceptScore W4300604358C99454951 @default.
- W4300604358 hasLocation W43006043581 @default.
- W4300604358 hasOpenAccess W4300604358 @default.
- W4300604358 hasPrimaryLocation W43006043581 @default.
- W4300604358 hasRelatedWork W2023189198 @default.
- W4300604358 hasRelatedWork W2024478301 @default.
- W4300604358 hasRelatedWork W2051595220 @default.
- W4300604358 hasRelatedWork W2063008526 @default.
- W4300604358 hasRelatedWork W2131382197 @default.
- W4300604358 hasRelatedWork W2283060978 @default.
- W4300604358 hasRelatedWork W2591792611 @default.
- W4300604358 hasRelatedWork W2940184018 @default.
- W4300604358 hasRelatedWork W4246079779 @default.
- W4300604358 hasRelatedWork W2172532223 @default.
- W4300604358 isParatext "false" @default.
- W4300604358 isRetracted "false" @default.
- W4300604358 workType "article" @default.